Equine Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Equine Healthcare Market is Segmented by Product (Vaccines, Pharmaceuticals (Parasiticides, Anti-Infectives, Anti-Inflammatory & Analgesics, and Other Pharmaceuticals), Medicinal Feed Additives, Diagnostics, and Other Products), Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Rabies, and Other Indications), Distribution Channel (Veterinary Hospitals and Clinics, E-Commerce, and Other Distribution Channels), and Geography (North America (United States, Canada, and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC and South Africa, and Rest of Middle East and Africa), and South America(Brazil, Argentina, and Rest of South America)). The report offers the value (in USD million) for the above segments.

Equine Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Equine Healthcare Market Size

Equine Healthcare Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 5.90 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Equine Healthcare Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Equine Healthcare Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Equine Healthcare Market Analysis

The Equine Healthcare Market is expected to register a CAGR of 5.9% during the forecast period.

The COVID-19 pandemic had a significant impact on the equine healthcare market initially due to strict social distancing guidelines imposed by many countries, which led to a shutdown of teaching, training, competitions, events, touristic activities, renting of infrastructures, trade, and sales of horses. For instance, according to a representative of the United States Equestrian Federation (USEF), the national governing body for horse sports in the United States, about 30% of all events originally scheduled on their 2020 show calendar was canceled. This severely impacted the revenue generation of the equine industry. In addition, this has also been anticipated to result in collateral consequences for the health and welfare of horses and ponies. However, with the countries being reopened again, the equine industry is also on track for a rebound. In addition, there were new product developments for the animal vaccine against COVID-19. For instance, in June 2022, the Ministry of Agriculture & Farmers Welfare (India) launched the Ancovax vaccine, an inactivated SARS-CoV-2 Delta (COVID-19) vaccine for animals, including equines. The vaccine was developed by the Indian Council of Agriculture Research (ICAR)-National Research Centre on Equines. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the market gained traction with the opening of the countries and new product launches globally.

Further, the rising animal health spending, increasing prevalence of equine diseases, and increasing uptake of animal insurance are among the major factors driving the growth of the market studied. For instance, in December 2021, the Asian Development Bank (ADB) signed an agreement with Zenex Animal Health India Private Limited to invest up to USD 10 million to increase Zenex's production and distribution of quality animal health care products and help boost farmer incomes by mitigating livestock disease risk. Such factors will likely boost the demand for equine healthcare, thereby contributing to the growth of the market studied.

The equine industry involves business, working animals, sports, and recreation, among others. There are a large number of horse races, shows, competitions, and recreational activities involving horses globally. Domestic and foreign horses are exported and imported permanently and temporarily to and from countries globally. As horses are prone to an array of equine diseases, equine healthcare products are in increasing demand. In addition, the risk and threat of spreading zoonotic diseases from horses are also driving the demand for equine healthcare products. For instance, according to a systemic review published in Vector Borne Zoonotic Dis. 2020, about 56 zoonotic pathogens have been identified in horses. Moreover, during the second quarter of 2022, the International Collating Centre reported 191 disease outbreaks from 13 countries. The reports covered 18 diseases/infections, of which strangles (n=77) was the most prevalent, followed by neurological EHV-1 (n=19). Thus, the high risk of the spread of a contagious equine disease is driving the equine market studied.

Thus, the rising animal health spending, increasing prevalence of equine diseases, and the increasing uptake of animal insurance are poised to accelerate the Equine Healthcare market globally, thereby driving the growth of the studied market over the forecast period. However, a shortage of skilled veterinarians will likely impede market growth.

Equine Healthcare Industry Overview

The Equine Healthcare market is slightly consolidated due to the presence of a few big companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known, including Zoetis, Boehringer Ingelheim International GmbH, Ceva, Merck & Co., Inc., Hallmarq Veterinary Imaging, Vetoquinol S.A., ESAOTE SPA, IDEXX Laboratories, Inc., Dechra Pharmaceuticals PLC, Elanco, among others.

Equine Healthcare Market Leaders

  1. Zoetis

  2. Boehringer Ingelheim International GmbH

  3. Ceva

  4. Merck & Co., Inc.

  5. Vetoquinol S.A.

  6. *Disclaimer: Major Players sorted in no particular order
Equine Healthcare Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Equine Healthcare Market News

  • In November 2021, Biosig Instruments Inc. launched a new type of the Insta-Pulse Equine heart rate monitor, the model 109.
  • In October 2022, Vetoquinol S.A. launched the Phovia dermatology system for equine veterinarians. Phovia can help heal common equine dermatological conditions, including surgical incisions, skin infections, and traumatic wounds, as a summer sore treatment program component.
  • In September 2021, Dechra Veterinary Products acquired the veterinary marketing and distribution rights to the ProVet APC (Autologous Platelet Concentrate) and ProVet BMC (Bone Marrow Concentrate) systems from Hassinger Biomedical. This significantly enhanced their product portfolio for equine healthcare.

Equine Healthcare Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Equine Diseases
    • 4.2.2 Rising Animal Health Spending and Increasing Uptake of Animal Insurance
  • 4.3 Market Restraints
    • 4.3.1 Shortage of Skilled Veterinarians
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Vaccines
    • 5.1.2 Pharmaceuticals
    • 5.1.2.1 Parasiticides
    • 5.1.2.2 Anti-Infectives
    • 5.1.2.3 Anti-Inflammatory & Analgesics
    • 5.1.2.4 Other Pharmaceuticals
    • 5.1.3 Medicinal Feed Additives
    • 5.1.4 Diagnostics
    • 5.1.5 Other Products
  • 5.2 By Indication
    • 5.2.1 Musculoskeletal Disorders
    • 5.2.2 Parasite Control
    • 5.2.3 Equine Herpes Virus
    • 5.2.4 Equine Encephalomyelitis
    • 5.2.5 Equine Influenza
    • 5.2.6 West Nile Virus
    • 5.2.7 Tetanus
    • 5.2.8 Rabies
    • 5.2.9 Other Indications
  • 5.3 By Distribution Channel
    • 5.3.1 Veterinary Hospitals and Clinics
    • 5.3.2 E-Commerce
    • 5.3.3 Other Distribution Channels
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Zoetis
    • 6.1.2 Boehringer Ingelheim International GmbH
    • 6.1.3 Ceva
    • 6.1.4 Merck & Co., Inc.
    • 6.1.5 Vetoquinol S.A.
    • 6.1.6 Hallmarq Veterinary Imaging
    • 6.1.7 ESAOTE SPA
    • 6.1.8 IDEXX Laboratories, Inc.
    • 6.1.9 Dechra Pharmaceuticals PLC
    • 6.1.10 Elanco
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Equine Healthcare Industry Segmentation

As per the scope of the report, equine healthcare includes health products and supplements to help maintain equine health and wellness.

The Equine Healthcare Market is Segmented by Product (Vaccines, Pharmaceuticals (Parasiticides, Anti-Infectives, Anti-Inflammatory & Analgesics, and Other Pharmaceuticals), Medicinal Feed Additives, Diagnostics, and Other Products), Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Rabies, and Other Indications), Distribution Channel (Veterinary Hospitals and Clinics, E-Commerce, and Other Distribution Channels), and Geography (North America (United States, Canada, and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC and South Africa, and Rest of Middle East and Africa), and South America(Brazil, Argentina, and Rest of South America)). The report offers the value (in USD million) for the above segments.

By Product Vaccines
Pharmaceuticals Parasiticides
Anti-Infectives
Anti-Inflammatory & Analgesics
Other Pharmaceuticals
Medicinal Feed Additives
Diagnostics
Other Products
By Indication Musculoskeletal Disorders
Parasite Control
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
Rabies
Other Indications
By Distribution Channel Veterinary Hospitals and Clinics
E-Commerce
Other Distribution Channels
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Equine Healthcare Market Research FAQs

What is the current Equine Healthcare Market size?

The Equine Healthcare Market is projected to register a CAGR of 5.9% during the forecast period (2025-2030)

Who are the key players in Equine Healthcare Market?

Zoetis, Boehringer Ingelheim International GmbH, Ceva, Merck & Co., Inc. and Vetoquinol S.A. are the major companies operating in the Equine Healthcare Market.

Which is the fastest growing region in Equine Healthcare Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Equine Healthcare Market?

In 2025, the North America accounts for the largest market share in Equine Healthcare Market.

What years does this Equine Healthcare Market cover?

The report covers the Equine Healthcare Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Equine Healthcare Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Equine Healthcare Industry Report

Statistics for the 2025 Equine Healthcare market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Equine Healthcare analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.